Contact | Print version | PDF version | Send article | RSS feed

Global Protein Therapeutics Market Dominated by Monoclonal Antibodies

11 Apr 2008 - According to the market research report "Global Protein Therapeutics Market Analysis", the Protein Therapeutic Market was valued in excess of US$ 57 Billion in 2006 and according to projections, it would grow at a CAGR 12.83% till 2010 The market is presently dominated by Monoclonal Antibodies and with double-digit growth projected for future, the segment is expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting double-digit growth rates.
 
One of the biggest opportunity areas in the Protein Therapeutics Market will be in the field of Biogenerics, which is expected to create a multi-billion dollar market in future.
 
The key findings of the market report include:
 
- US is the largest market for therapeutic proteins in the world followed by Europe and Japan.
 
- Insurance reimbursement is a major factor that decides the success of protein therapeutics.
 
- Growth in protein therapeutic market will create new opportunities for the drug discovery Contract Research Organizations (CROs).
 
- High expenditure on R&D and high rate of failure in phase-3 clinical trials remains a major challenge for the global protein therapeutics market.
 
- Until recently, protein therapeutics faced little generic threat; however, this is likely to change in future with regulatory pathways for the approval of generics already present in Europe and Asia and to be introduced in US by 2009.

Further information: http://www.researchandmarkets.com/product/ce69c1/global_protein_therapeutics_market_analysis